<bill session="114" type="h" number="4983" updated="2019-05-09T23:32:58Z">
  <state datetime="2016-04-18">REFERRED</state>
  <status>
    <introduced datetime="2016-04-18"/>
  </status>
  <introduced datetime="2016-04-18"/>
  <titles>
    <title type="official" as="introduced">To provide information to prescribers in Federally qualified health centers and facilities of the Indian Health Service on best practices for prescribing naloxone.</title>
    <title type="display">To provide information to prescribers in Federally qualified health centers and facilities of the Indian Health Service on best practices for prescribing naloxone.</title>
  </titles>
  <sponsor bioguide_id="G000568"/>
  <cosponsors/>
  <actions>
    <action datetime="2016-04-18">
      <text>Introduced in House</text>
    </action>
    <action datetime="2016-04-18" state="REFERRED">
      <text>Referred to the Committee on Energy and Commerce, and in addition to the Committee on Natural Resources, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.</text>
    </action>
    <action datetime="2016-04-18">
      <text>Referred to the Committee on Energy and Commerce, and in addition to the Committee on Natural Resources, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.</text>
    </action>
    <action datetime="2016-04-22">
      <text>Referred to the Subcommittee on Health.</text>
    </action>
    <action datetime="2016-04-27">
      <text>Referred to the Subcommittee on Indian, Insular and Alaska Native Affairs.</text>
    </action>
  </actions>
  <committees>
    <committee subcommittee="" code="HSII" name="House Natural Resources" activity="Referral"/>
    <committee subcommittee="Indigenous Peoples of the United States" code="HSII24" name="House Natural Resources" activity="Referral"/>
    <committee subcommittee="" code="HSIF" name="House Energy and Commerce" activity="Referral"/>
    <committee subcommittee="Health" code="HSIF14" name="House Energy and Commerce" activity="Referral"/>
  </committees>
  <relatedbills>
    <bill type="h" session="114" relation="unknown" number="5189"/>
  </relatedbills>
  <subjects>
    <term name="Health"/>
    <term name="Drug trafficking and controlled substances"/>
    <term name="Drug, alcohol, tobacco use"/>
    <term name="Health information and medical records"/>
    <term name="Health promotion and preventive care"/>
    <term name="Indian social and development programs"/>
    <term name="Minority health"/>
    <term name="Prescription drugs"/>
  </subjects>
  <amendments/>
  <summary date="2016-04-18T04:00:00Z" status="Introduced in House">This bill requires the Department of Health and Human Services to provide information to prescribers in federally qualified health centers and Indian Health Service facilities on best practices for prescribing naloxone (a prescription drug used to rapidly reverse an opioid overdose) for patients a provider identifies as having an elevated risk of opioid overdose. (Opioids are drugs with effects similar to opium, such as heroin and certain pain medications.)</summary>
  <committee-reports/>
</bill>
